Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab long-term extension in rheumatoid arthritis
NCT00720798Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Primary completion
- Apr 2013
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 34
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Sep 2005; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00720798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720798.